… RVB-003 has been awarded orphan drug designation by the FDA for … . BioWorld Science Regulatory Dermatologic FDA Orphan drug

… kinase (BTK) inhibitor, was granted orphan drug designation (ODD) by the FDA … . Sanofi. Press release: Rilzabrutinib granted orphan drug designation in the US for …

… Administration (FDA) has granted orphan drug designation to rilzabrutinib, an investigational … approved medicine. FDA grants orphan drug designation to investigational therapies addressing … of Development, Rare Diseases “Orphan drug designation for these two …

… Administration (FDA) has granted orphan drug designation to rilzabrutinib, an investigational … approved medicine. FDA grants orphan drug designation to investigational therapies addressing … , rare diseases, said “Orphan drug designation for these two rare …

… The FDA has granted orphan drug designation to rilzabrutinib … of these conditions. “Orphan drug designation for these two … company’s statement. The orphan drug designation for IgG4-related … . The FDA’s orphan drug designation provides incentives including …

… Administration (FDA) has granted orphan drug designation to Rilzabrutinib, an investigational … approved medicine. FDA grants orphan drug designation to investigational therapies addressing … , Rare Diseases said, “Orphan drug designation for these two rare …

… - Nasdaq) Rilzabrutinib granted orphan drug designation in the US for … Administration (FDA) has granted orphan drug designation to rilzabrutinib, an investigational … approved medicine. FDA grants orphan drug designation to investigational therapies addressing …

… Administration (FDA) has granted orphan drug designation to rilzabrutinib, an investigational … approved medicine. FDA grants orphan drug designation to investigational therapies addressing … of Development, Rare Diseases “Orphan drug designation for these two …

… -z has also been granted Orphan Drug Designation by the US FDA …

… . The FDA also granted Uplizna Orphan Drug Designation for the treatment of …